Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $276,560 (100.0% shares, 0.0% debt)

Holdings (7)

RVMD Revolution Medicines Inc 35.9%

Value ($000) $99,156 Shares 4,577,840 Est. Cost $34.24 Unrealized -28.1%

— NGM Biopharmaceuticals Inc 26.8%

Value ($000) $73,998 Shares 18,136,735 Est. Cost $27.77 Unrealized —

— RAPT Therapeutics Inc 17.8%

Value ($000) $49,189 Shares 2,680,621 Est. Cost $19.03 Unrealized —

TNYA Tenaya Therapeutics, Inc. 9.7%

Value ($000) $26,791 Shares 9,400,290 Est. Cost $21.49 Unrealized -86.9%

ORIC ORIC Pharmaceuticals Inc. 7.4%

Value ($000) $20,339 Shares 3,568,181 Est. Cost $28.69 Unrealized -81.8%

— Surrozen, Inc. 2.0%

Value ($000) $5,567 Shares 9,248,129 Est. Cost $6.95 Unrealized —

— eFFECTOR Therapeutics Inc 0.5%

Value ($000) $1,520 Shares 4,309,329 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RVMD	Revolution Medicines Inc	4,577,840	$99,156	35.9%	$34.24	-28.1%	COM	76155X100
—	NGM Biopharmaceuticals Inc	18,136,735	$73,998	26.8%	$27.77	—	COM	62921N105
—	RAPT Therapeutics Inc	2,680,621	$49,189	17.8%	$19.03	—	COM	75382E109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$26,791	9.7%	$21.49	-86.9%	COM	87990A106
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$20,339	7.4%	$28.69	-81.8%	COM	68622P109
—	Surrozen, Inc.	9,248,129	$5,567	2.0%	$6.95	—	COM	86889P109
—	eFFECTOR Therapeutics Inc	4,309,329	$1,520	0.5%	$14.05	—	COM	28202V108